BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Dr Narjiss Berrada speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the landscape of breast cancer in Morocco.
She describes that breast cancer is the most common cancer amongst females in Morrocco and explains how it is detected and treated.
Due to advances in detection, Dr Berrada states that half of the patients now present with T1 and T2 tumours and the next steps are to introduce routine mammographic screening programs.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Genomic testing: Awareness and effective communication between healthcare professionals and patients
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
Choosing Wisely in radiology Tanzania
Why tumour markers are not recommended as screening tests
Lung cancer screening and treatment in the Philippines
Choosing Wisely to mitigate financial toxicity in cancer care in Africa
Advancing breast cancer diagnosis in the developing world
Global adoption of single-shot targeted IORT for breast cancer